Spatial correlation maps of the hippocampus with cerebrospinal fluid biomarkers and cognition in Alzheimer's disease: A longitudinal study

This study is an observational study that takes the existing longitudinal data from Alzheimer's disease Neuroimaging Initiative to examine the spatial correlation map of hippocampal subfield atrophy with CSF biomarkers and cognitive decline in the course of AD. This study included 421 healthy c...

Full description

Bibliographic Details
Main Authors: Liu, C. (Author), Liu, G. (Author), Qiu, A. (Author), the Alzheimer's Disease Neuroimaging Initiative (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2021
Subjects:
MRI
Online Access:View Fulltext in Publisher
LEADER 04613nam a2201033Ia 4500
001 10.1002-hbm.25414
008 220427s2021 CNT 000 0 und d
020 |a 10659471 (ISSN) 
245 1 0 |a Spatial correlation maps of the hippocampus with cerebrospinal fluid biomarkers and cognition in Alzheimer's disease: A longitudinal study 
260 0 |b John Wiley and Sons Inc  |c 2021 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1002/hbm.25414 
520 3 |a This study is an observational study that takes the existing longitudinal data from Alzheimer's disease Neuroimaging Initiative to examine the spatial correlation map of hippocampal subfield atrophy with CSF biomarkers and cognitive decline in the course of AD. This study included 421 healthy controls (HC), 557 patients of stable mild cognitive impairment (s-MCI), 304 Alzheimer's Disease (AD) patients, and 241 subjects who converted to be AD from MCI (c-MCI), and 6,525 MRI scans in a period from 2004 to 2019. Our findings revealed that all the hippocampal subfields showed their accelerated atrophy rate from cognitively normal aging to stable MCI and AD. The presubiculum, dentate gyrus, and fimbria showed greater atrophy beyond the whole hippocampus in the HC, s-MCI, and AD groups and corresponded to a greater decline of memory and attention in the s-MCI group. Moreover, the higher atrophy rates of the subiculum and CA2/3, CA4 were also associated with a greater decline in attention in the s-MCI group. Interestingly, patients with c-MCI showed that the presubiculum atrophy was associated with CSF tau levels and corresponded to the onset age of AD and a decline in attention in patients with c-MCI. These spatial correlation findings of the hippocampus suggested that the hippocampal subfields may not be equally impacted by normal aging, MCI, and AD, and their atrophy was selectively associated with declines in specific cognitive domains. The presubiculum atrophy was highlighted as a surrogate marker for the AD prognosis along with tau pathology and attention decline. © 2021 The Authors. Human Brain Mapping published by Wiley Periodicals LLC. 
650 0 4 |a aged 
650 0 4 |a Aged 
650 0 4 |a Aged, 80 and over 
650 0 4 |a aging 
650 0 4 |a Aging 
650 0 4 |a Alzheimer disease 
650 0 4 |a Alzheimer disease 
650 0 4 |a Alzheimer Disease 
650 0 4 |a amygdala 
650 0 4 |a amyloid beta protein[1-42] 
650 0 4 |a Article 
650 0 4 |a atrophy 
650 0 4 |a Atrophy 
650 0 4 |a biological marker 
650 0 4 |a biological marker 
650 0 4 |a Biomarkers 
650 0 4 |a brain atrophy 
650 0 4 |a brain size 
650 0 4 |a cerebrospinal fluid 
650 0 4 |a cognition 
650 0 4 |a cognitive defect 
650 0 4 |a Cognitive Dysfunction 
650 0 4 |a cognitive function 
650 0 4 |a comparative study 
650 0 4 |a controlled study 
650 0 4 |a CSF tau pathology 
650 0 4 |a dentate gyrus 
650 0 4 |a diagnostic imaging 
650 0 4 |a disease exacerbation 
650 0 4 |a disease exacerbation 
650 0 4 |a Disease Progression 
650 0 4 |a executive function 
650 0 4 |a female 
650 0 4 |a follow up 
650 0 4 |a granule cell 
650 0 4 |a hippocampal subfields 
650 0 4 |a hippocampus 
650 0 4 |a Hippocampus 
650 0 4 |a human 
650 0 4 |a Humans 
650 0 4 |a language 
650 0 4 |a Longitudinal Studies 
650 0 4 |a longitudinal study 
650 0 4 |a longitudinal study 
650 0 4 |a Magnetic Resonance Imaging 
650 0 4 |a major clinical study 
650 0 4 |a male 
650 0 4 |a memory 
650 0 4 |a mild cognitive impairment 
650 0 4 |a Mini Mental State Examination 
650 0 4 |a molecular layer 
650 0 4 |a MRI 
650 0 4 |a neuroimaging 
650 0 4 |a neuropsychological test 
650 0 4 |a nuclear magnetic resonance imaging 
650 0 4 |a observational study 
650 0 4 |a onset age 
650 0 4 |a pathology 
650 0 4 |a pathophysiology 
650 0 4 |a phosphoprotein 
650 0 4 |a physiology 
650 0 4 |a positron emission tomography 
650 0 4 |a priority journal 
650 0 4 |a protein cerebrospinal fluid level 
650 0 4 |a Rey auditory verbal learning test 
650 0 4 |a right hemisphere 
650 0 4 |a subiculum 
650 0 4 |a tau protein 
650 0 4 |a the onset of AD 
650 0 4 |a three-dimensional imaging 
650 0 4 |a trail making test 
650 0 4 |a very elderly 
700 1 |a Liu, C.  |e author 
700 1 |a Liu, G.  |e author 
700 1 |a Qiu, A.  |e author 
700 1 |a the Alzheimer's Disease Neuroimaging Initiative  |e author 
773 |t Human Brain Mapping